Last reviewed · How we verify

NCT05580705

Effects of Vibration Therapy in Addition to Routine Physical Therapy in Patients With Diabetic Neuropathy

Completed NA Last updated 6 April 2023
What this trial tests

NA trial testing Routine Physical Therapy in Diabetic Peripheral Neuropathy in 72 participants. Completed in 22 February 2023.

Timeline
22 September 2022
Primary endpoint
22 February 2023
22 February 2023

Quick facts

Lead sponsorUniversity of Lahore
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment72
Start date22 September 2022
Primary completion22 February 2023
Estimated completion22 February 2023
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

University of Lahore

Who can join

Adults 40 to 75, any sex, with Diabetic Peripheral Neuropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is aimed to determine the effects of sole-foot vibration therapy on pain intensity, static and dynamic balance, functional status and satisfaction to the intervention applied on patients with peripheral neuropathy due to type 2 diabetes mellitus.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of vibration therapy with routine physical therapy on pain, balance, and functional disability in diabetic neuropathy patients: a randomised controlled trial.
    Bashir S, Jamil A, Ali S. · · 2025 · cited 1× · PMID 40269358 · DOI 10.47391/jpma.20058

Verify or expand the search:

Other trials of Routine Physical Therapy

Trials testing the same drug.

Other recruiting trials for Diabetic Peripheral Neuropathy

Currently open trials in the same condition.

Other University of Lahore trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05580705.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing